AzTrials
AzTrials

Biting ForcesPhase 2NCT07007572

Evaluation Of Marginal Bone Height Changes And Biting Force In Screw Retained Implant Prostheses Using Reinforced Resin Vs Monolithic Zirconium

A Phase 2 study testing Digitally-fabricated implant supported supra-structure fabricated from reinforced resin and Digitally-fabricated implant supported supra-structure fabricated from monolithic zirconia in people with Biting Forces and Bone; Change, Diabetic (Manifestation), run by Cairo University at 2 sites in Egypt.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This studies aims to compare the behavior of recently introduced resin reinforces compared to monolithic zirconia Read more about this study

Who is it for?
Ages 30 to 60 yearsHealthy volunteers can take part
What is being tested?
Digitally-fabricated implant supported supra-structure fabricated from reinforced resin and Digitally-fabricated implant supported supra-structure fabricated from monolithic zirconia
Could I receive a placebo?
No, everyone receives an active treatment
How many people
14 participants
Where
2 sitesEgypt
Study dates
31 Dec 2024to 1 Mar 2026
Phase
Phase 2
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 30 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Mandibular Class II, partially edentulous patients that enables measuring the marginal bone height changes and values of biting forces intra-orally.
  • Fully dentulous edentulous opposing Maxillary arch.
  • Patients with normal class I jaw relationship.
  • Patients that require fixed restorations for functional and esthetic reasons
  • Age range (30-60 years).
  • Cooperative patients those are willing to attend all follow-up periods.
Show all 9Show fewer
  • Patients with healthy attached mucosa of appropriate thickness free from any inflammation.
  • Patients with healthy bone of appropriate thickness, width and height free from any inflammation.
  • Patients without any medical conditions that contraindicates implant placement.

Who cannot join

  • Patients with Parkinson's disease
  • Patients with xerostomia.
  • Patients with a history of allergy to resins and/ or zirconia.
  • Patients with a medical systematic condition that contraindicate implant placement.
  • Patients smoking more than 10 cigarettes per day.
  • Patients with pathological changes of residual ridges as recurrent or persistent ulcers, osteomyelitis and infections.
  • Patients with large irregular bony exostosis.
  • Patients with medical or psychological conditions as physical disability or mental retardation that hinder cooperation in the follow up visits and answering the questionnaires.

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Mahmoud Saleh Fayed, Assistant lecturer contact

00201141565676

mahmoud.fayed@dentistry.cu.edu.eg

Reham Osman, Professor contact

rehambosman@gmail.com

Egypt2 sites, 2 recruiting
  • Faculty of Dentistry, Cairo University

    Cairo, Cairo Governorate, 12613

    Recruiting
  • Faculty of Dentistry, Cairo University

    Cairo, Cairo Governorate, 12613

    Faculty of Dentistry Cairo university, 002010 02159535, adj@dentistry.cu.edu.eg

    mahmoud Saleh Fayed, Assistant lecturer

    Recruiting

Other trials in Egypt

About this study

Official title: Evaluation Of Marginal Bone Height Changes And Biting Force In Screw Retained Implant Prostheses Using Reinforced Resin Vs Monolithic Zirconium Used In Unilateral Distal Extension Cases

This studies aims to compare the behavior of recently introduced resin reinforces compared to monolithic zirconia

Read the detailed description

The clinical success of implant-supported prostheses is significantly influenced by the material used, as it directly affects both prosthetic longevity and patient satisfaction. Monolithic zirconia, despite its widespread popularity, presents notable clinical challenges. Its excessive rigidity often leads to mechanical failures such as chipping, fractures, and increased wear of the opposing dentition. Moreover, zirconia's limited ability to absorb and dissipate occlusal forces can result in elevated stresses on implant components, contributing to screw loosening or fractures and necessitating frequent maintenance interventions. These complications not only escalate the overall cost of care but also negatively impact patient outcomes, leading to discomfort, inconvenience, and dissatisfaction. Consequently, there is a pressing need to explore alternative restorative materials that maintain strength and esthetic appeal while mitigating these clinical issues. Biomimetic reinforced resin composites, engineered to emulate the mechanical behavior of natural tooth structures, offer a promising solution. By more effectively absorbing and distributing occlusal forces, these materials may reduce stress on both prostheses and surrounding tissues. If clinically validated, biomimetic resins could lead to fewer mechanical complications, improved bone preservation, and enhanced overall durability of implant-supported prostheses. The clinical implications of adopting biomimetic reinforced resin are substantial; a material that reduces the frequency of repairs and replacements compared to monolithic zirconia would mark a significant advancement in prosthetic dentistry, offering clinicians a superior restorative option and improving patient satisfaction through more stable, long-term outcomes.

To investigate this, mandibular Class II partially edentulous patients will be recruited from the outpatient clinic at the Department of Prosthodontics, Cairo University, based on specific inclusion criteria. After obtaining informed consent and conducting a comprehensive clinical examination, each patient will receive two implants in the edentulous area, restored initially with a screw-retained bridge made of milled monolithic zirconia. After six months, the zirconia bridge will be replaced with a milled resin-reinforced composite bridge. The sequence of material placement will be randomized for each participant, ensuring that each patient uses both materials sequentially without a washout period.

Intraoral scans and digital bite registrations will be performed, and prostheses will be designed using CAD software. Fabrication will follow standardized milling techniques for both zirconia and resin-reinforced composite materials. Bone levels around the implants will be evaluated using long cone parallel periapical radiographs, with measurements recorded at 0 and 6 months during each material phase. This approach allows for direct comparison of the two materials' effects on peri-implant bone health.

Biting forces will also be assessed using an occlusal force meter. A reference bite force will be measured on the intact side, followed by measurements on the intervention side after the placement of each restorative material. Each measurement will be repeated five times and averaged to ensure accuracy. All data regarding bone levels and biting forces will be recorded, tabulated, and statistically analyzed in the presence of an outcome assessor during clinical visits. Through this study design, it will be possible to evaluate the mechanical and biological performance of monolithic zirconia versus biomimetic reinforced resin composites in implant-supported prostheses.

Being tested
Digitally-fabricated implant supported supra-structure fabricated from reinforced resin, Digitally-fabricated implant supported supra-structure fabricated from monolithic zirconia
Keywords
biting forces, Bacterial Adhesion, color stability, soft tissue response, prosthetic complication

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Digitally-fabricated implant supported supra-structure fabricated from reinforced resinCombination product

    A comprehensive clinical examination with an understanding of patients' chief complaints and needs will be carried out. For each patient, two implants will be placed in the edentulous area, and the patient will receive a screw-retained bridge supported by both implants made of milled monolithic zirconia (Dental Direkt Zirconia, Germany). After 6 months, the zirconia restoration will be replaced with a milled resin-reinforced composite (Nanoska G Plus, USA), allowing the same patient to use the new restoration for another 6 months. Randomization will be performed to determine the sequence of bridge material for each participant. Accordingly, the two restorations will be sequentially delivered to each participant with no gap (wash-up period) between them. Consent will be signed by the selected participants after explaining the detailed information of the trial.

  • Digitally-fabricated implant supported supra-structure fabricated from monolithic zirconiaCombination product

    Digitally-fabricated implant supported supra-structure fabricated from monolithic zirconia

Study groups in NCT07007572
Study groupRoleWhat they receive
patients who receives a screw retained monolithic zirconia bridgeActive comparatorDigitally-fabricated implant supported supra-structure fabricated from monolithic zirconia
Receives: Combination Product: Digitally-fabricated implant supported supra-structure fabricated from reinforced resin
patients who receives a screw retained resin reinforced bridgeExperimentalDigitally-fabricated implant supported supra-structure fabricated from reinforced resin
Receives: Combination Product: Digitally-fabricated implant supported supra-structure fabricated from monolithic zirconia

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Measurement of the Bone height changes (bone level)

    Change in marginal bone height (in millimeters) measured using long cone parallel peri-apical radiographs at baseline and 6 months for each prosthetic material phase (monolithic zirconia and resin-reinforced). Radiographs will be taken at four time points:

    Start of phase 1 (zirconia, baseline)

    End of phase 1 (zirconia, 6 months)

    Start of phase 2 (resin-reinforced, baseline)

    End of phase 2 (resin-reinforced, 6 months)

    Bone level will be assessed on the mesial and distal surfaces of each implant using a standardized radiographic protocol.

    Measured: 6 months for each arm

Secondary outcomes (1)
  1. Average Maximum Biting Force

    Average maximum static biting force (in Newtons) recorded using an occlusal force meter. For each prosthetic material phase (monolithic zirconia and resin-reinforced), patients will bite on the sensor five times per side. The average value from the intervention side (restored side) will be compared with that of the intact side. Measurements will be taken after prosthetic delivery for both phases and compared using statistical analysis to assess relative performance.

    Time Points:

    After placement of zirconia prosthesis

    After placement of resin-reinforced prosthesis

    Tool Used:

    Occlusal force meter with digital sensor, positioned on molars of both the intact and intervention sides.

    Measured: 6 months for each arm

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Jun 2025
  2. Study start31 Dec 2024
  3. Primary completion1 Jan 2026 (estimated)
  4. Study completion1 Mar 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
14 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07007572
Sponsor's protocol ID
31-12-24
Status last verified
Jun 2025
First submitted
18 May 2025
Last updated
6 Jun 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: At this time, no final decision has been made regarding the sharing of individual participant data (IPD). The decision will depend on factors such as participant consent, institutional policies, data privacy considerations, and the potential for future collaborative research. If data sharing is approved, it will comply with all applicable ethical and legal standards.

Publications

  • Roh, K.-W. et al. (2019) 'A prospective clinical of lithium disilicate pressed zirconia and monolithic zirconia in posterior implant-supported prostheses: A 24-month follow-up', The Journal of Korean Academy of Prosthodontics, 57(2), p. 134. doi: 10.4047/jkap.2019.57.2.134.

  • Nitschke I, Moede C, Hopfenmuller W, Sobotta BAJ, Koenig A, Jockusch J. Validation of a New Measuring Instrument for the Assessment of Bite Force. Diagnostics (Basel). 2023 Nov 21;13(23):3498. doi: 10.3390/diagnostics13233498.

    PubMed 38066739
  • Liu, Y., Wang, S. and Chen, J. (2023) 'Challenges of monolithic zirconia in implant prosthodontics: Biting forces and maintenance considerations', Journal of Prosthetic Dentistry, 132(1), pp. 75-82. Available at: https://www.journals.elsevier.com/the-journal- of-prosthetic-dentistry.

  • Lee, K. H., Patel, M. A. and Smith, A. D. (2023) 'Enhancing function and esthetics in partial edentulism: The role of biomimetic materials', Journal of Prosthetic Dentistry, 130(2), pp. 150-158. Available at: https://www.journals.elsevier.com/the-journal-of-prosthetic- dentistry.

  • Gomez, P. H. et al. (2023) 'Advances in resin composites: A review of biomimetic approaches in prosthetic dentistry', Journal of Prosthetic Dentistry. Available at: https://www.journals.elsevier.com/the-journal-of-prosthetic-dentistry.

  • Ahmed, N., Patel, A. and Zhang, X. (2024) 'Prosthetic Rehabilitation of Edentulous Patients: A Systematic Review of Complications and Management', International Journal of Prosthodontics, 37(2), pp. 214-223. doi: 10.11607/ijp.7698.

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing Digitally-fabricated implant supported supra-structure fabricated from reinforced resin and Digitally-fabricated implant supported supra-structure fabricated from monolithic zirconia in people with Biting Forces and Bone; Change, Diabetic (Manifestation), run by Cairo University at 2 sites in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 6 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Mahmoud Saleh Fayed, Assistant lecturer (00201141565676, mahmoud.fayed@dentistry.cu.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Measurement of the Bone height changes (bone level) (time frame: 6 months for each arm). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07007572, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Jun 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in